We could not find any results for:
Make sure your spelling is correct or try broadening your search.
DiaMedica Therapeutics Inc is a clinical-stage biopharmaceutical company. The company is principally engaged in the business activity of developing treatments for unmet clinical needs or where no therapies are available with a primary focus on chronic kidney disease and acute ischemicstroke. Its pip... DiaMedica Therapeutics Inc is a clinical-stage biopharmaceutical company. The company is principally engaged in the business activity of developing treatments for unmet clinical needs or where no therapies are available with a primary focus on chronic kidney disease and acute ischemicstroke. Its pipeline product DM199 is a recombinant form of human tissue kallikrein-1. Show more
DiaMedica Therapeutics Inc. (Nasdaq: DMAC), a clinical-stage biopharmaceutical company focused on developing novel treatments for neurological disorders and cardio-renal disease, today announced...
Conference Call and Webcast March 20 at 8:00 AM Eastern Time / 7:00 AM Central Time ReMEDy2 Clinical Site Activation Commenced in December 2023 Strengthened Management Team with Lorianne Masuoka...
DiaMedica Presents the Protocol and Rationale for ReMEDy2, a Pivotal Trial in Patients Suffering Acute Ischemic Stroke Ineligible for tPA and/or Mechanical Thrombectomy DiaMedica Therapeutics...
Executive with Strong Track Record in Advancing Pipelines Through Clinical Development DiaMedica Therapeutics Inc. (Nasdaq: DMAC), a clinical-stage biopharmaceutical company focused on developing...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0.03 | 1.19521912351 | 2.51 | 2.6 | 2.4 | 7254 | 2.51852393 | CS |
4 | -0.134 | -5.01121914734 | 2.674 | 3.2 | 2.26 | 34612 | 2.67119551 | CS |
12 | -0.32 | -11.1888111888 | 2.86 | 3.34 | 2.26 | 37755 | 2.84382879 | CS |
26 | 0.42 | 19.8113207547 | 2.12 | 3.34 | 2.1 | 43771 | 2.73762154 | CS |
52 | 0.84 | 49.4117647059 | 1.7 | 4.75 | 1.57 | 79481 | 3.11827859 | CS |
156 | -6.69 | -72.4810400867 | 9.23 | 9.84 | 1.12 | 108916 | 3.41092185 | CS |
260 | -0.75 | -22.7963525836 | 3.29 | 10.88 | 1.12 | 101078 | 4.37623501 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions